The DEA lowered the domestic output quota many of the method to zero in 1981 when the final American producer stopped rendering it; Congress took the unusual stage of passing a Exclusive act that moved Quaalude to Schedule I in 1983; and also the DEA undertook an energetic diplomatic effort to shut down methaqualone manufacturing in other countries